These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28489008)

  • 1. [Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures?].
    Thorsdottir G; Benedikz E; Thorgeirsdottir SA; Johannsson M
    Laeknabladid; 2017 Mai; 103(5):231-235. PubMed ID: 28489008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton Pump Inhibitors, But Not H2-receptor Antagonists, Are Associated With Incident Fractures Among Kidney Transplant Recipients.
    Lyu B; Jorgenson MR; Hansen KE; Djamali A; Astor BC
    Transplantation; 2020 Dec; 104(12):2609-2615. PubMed ID: 32058466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dose and type of proton pump inhibitor use on risk of fractures and osteoporosis treatment in older Australian women: A prospective cohort study.
    van der Hoorn MMC; Tett SE; de Vries OJ; Dobson AJ; Peeters GMEEG
    Bone; 2015 Dec; 81():675-682. PubMed ID: 26319499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of fracture risk between proton pump inhibitors and histamine-2 receptor antagonists in ANCA-associated vasculitis patients: a nested case-control study.
    Miyano S; Michihata N; Sada KE; Uda K; Matsui H; Fushimi K; Nangaku M; Yasunaga H
    Rheumatology (Oxford); 2021 Apr; 60(4):1717-1723. PubMed ID: 33067623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Osteoporos Int; 2006; 17(6):807-16. PubMed ID: 16520889
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.
    Abrahamsen B; Vestergaard P
    Bone; 2013 Nov; 57(1):269-71. PubMed ID: 23973557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship among proton pump inhibitors, bone disease and fracture.
    Targownik LE; Leslie WD
    Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
    Fusaro M; D'Arrigo G; Pitino A; Iervasi G; Tentori F; Robinson B; Aghi A; Bieber B; Mccullogh K; Fabris F; Plebani M; Giannini S; Gallieni M; Tripepi G
    J Bone Miner Res; 2019 Dec; 34(12):2238-2245. PubMed ID: 31365145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture risk of young adults receiving proton-pump inhibitors and H2-receptor antagonists.
    Fedida B; Schermann H; Ankory R; Rotman D; Shichman I; Yoffe V; Shlaifer A; Luger E
    Int J Clin Pract; 2019 May; 73(5):e13339. PubMed ID: 30829427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
    Lau YT; Ahmed NN
    Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Meta-analysis: risk of fractures with acid-suppressing medication.
    Kwok CS; Yeong JK; Loke YK
    Bone; 2011 Apr; 48(4):768-76. PubMed ID: 21185417
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone up on proton pump inhibitors and fracture risk.
    Gendreau-Webb R
    Nursing; 2007 Oct; 37(10):60-1. PubMed ID: 17906557
    [No Abstract]   [Full Text] [Related]  

  • 13. Proton pump inhibitors increase the incidence of bone fractures in hepatitis C patients.
    Mello M; Weideman RA; Little BB; Weideman MW; Cryer B; Brown GR
    Dig Dis Sci; 2012 Sep; 57(9):2416-22. PubMed ID: 22615013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
    Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
    Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors and bone fractures?
    Laine L
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S21-6. PubMed ID: 19262543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
    Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
    J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Proton pump inhibitors and their effect on the bone].
    Ječmenová M; Kroupa R
    Vnitr Lek; 2016 Feb; 62(2):139-46. PubMed ID: 27172441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton pump inhibitor use and the risk of fractures among an older adult cohort.
    Harding BN; Weiss NS; Walker RL; Larson EB; Dublin S
    Pharmacoepidemiol Drug Saf; 2018 Jun; 27(6):596-603. PubMed ID: 29493043
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2006 Aug; 79(2):76-83. PubMed ID: 16927047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Clinical Characteristics of Fractures in Pediatric Patients Exposed to Proton Pump Inhibitors.
    Fleishman N; Richardson T; Attard T
    J Pediatr Gastroenterol Nutr; 2020 Jun; 70(6):815-819. PubMed ID: 32443038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.